人獣共通感染症治療の世界市場レポート2025年

人獣共通感染症治療の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.6％で548億4,000万米ドルに成長します。予測期間の成長は、気候変動と環境要因、政府および国際的な資金調達、医療技術の進歩、規制当局の支援と承認の合理化、共同研究開発に起因すると考えられます。予測期間の主な動向としては、広域抗ウイルス薬の開発、世界の保健インフラの強化、診断技術の進歩、ワクチン開発プラットフォームの成長、予防対策の重視などが挙げられます。

今後5年間の成長率6.6%という予測は、この市場の前回予測からの0.4%という小幅な減少を反映しています。この減少は主に米国と他国との間の関税の影響によるものです。治療薬や診断キットの国境を越えた出荷が制限されることで、人獣共通感染症対策プログラムが弱体化し、発生時の対応コストが上昇する可能性があります。

また、相互関税や、貿易緊張の高まりと制限による世界経済と貿易への悪影響により、その影響はより広範囲に及ぶと思われます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の人獣共通感染症治療：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の人獣共通感染症治療市場：成長率分析
• 世界の人獣共通感染症治療市場の実績：規模と成長, 2019-2024
• 世界の人獣共通感染症治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界の人獣共通感染症治療：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界の人獣共通感染症治療市場：疾患タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 狂犬病
• 結核
• マラリア
• リーシュマニア症
• エボラウイルス病
• その他の疾患タイプ
• 世界の人獣共通感染症治療市場：薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗真菌
• 抗菌
• 抗生物質
• その他の薬剤クラス
• 世界の人獣共通感染症治療市場、原因物質別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細菌
• ウイルス
• 線虫
• げっ歯類
• ダニ
• その他の原因物質
• 世界の人獣共通感染症治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口
• 外用
• その他の投与経路
• 世界の人獣共通感染症治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• その他の流通チャネル
• 世界の人獣共通感染症治療市場、狂犬病、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 曝露後予防（PEP）
• 曝露前予防（PrEP）
• 世界の人獣共通感染症治療市場、結核、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 潜在性結核の治療
• 活動性結核治療
• 世界の人獣共通感染症治療市場、マラリア、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 熱帯熱マラリア原虫
• 三日熱マラリア原虫
• その他のマラリアの種類
• 世界の人獣共通感染症治療市場、リーシュマニア症、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 内臓リーシュマニア症
• 皮膚リーシュマニア症
• 粘膜皮膚リーシュマニア症
• 世界の人獣共通感染症治療市場、エボラウイルス感染症、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 曝露前ワクチン接種
• 曝露後治療
• 世界の人獣共通感染症治療市場、その他の疾患タイプ、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• ジカウイルス
• ラッサ熱
• 黄熱病
• チクングニア熱

第7章 地域別・国別分析

• 世界の人獣共通感染症治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の人獣共通感染症治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 人獣共通感染症治療市場：競合情勢
• 人獣共通感染症治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• AstraZeneca plc
• Novartis International AG
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Teva Pharmaceutical Industries Ltd.
• Zoetis Inc.
• Boehringer Ingelheim International GmbH
• Elanco Animal Health Incorporated
• IDEXX Laboretories Inc.
• Hikma Pharmaceuticals PLC.
• Ceva Sante Animale
• Vir Biotechnology Inc.
• Virbac

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 人獣共通感染症治療市場2029：新たな機会を提供する国
• 人獣共通感染症治療市場2029：新たな機会を提供するセグメント
• 人獣共通感染症治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Treatment for zoonotic diseases encompasses medical interventions and therapies designed to diagnose, manage, and prevent illnesses caused by pathogens transmitted between animals and humans. This treatment regimen typically combines medication, vaccination, hygiene protocols, and control measures to minimize transmission and alleviate the impact of these infections on both animal and human communities.

The primary diseases addressed in zoonotic disease treatment include rabies, tuberculosis, malaria, leishmaniasis, Ebola virus disease, and others. Rabies, for instance, is a viral illness characterized by acute inflammation of the brain in humans and other mammals, commonly transmitted through the bite of an infected animal. Zoonotic disease treatment encompasses various drug classes such as anti-fungal, anti-bacterial, antibiotics, and others, targeting diverse agents such as bacteria, viruses, nematodes, rodents, ticks, and others. Administration routes comprise oral, topical, and others, with distribution occurring through channels such as hospital pharmacies, retail pharmacies, online pharmacies, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.

The zoonotic disease treatment market research report is one of a series of new reports from The Business Research Company that provides zoonotic disease treatment market statistics, including zoonotic disease treatment industry global market size, regional shares, competitors with a zoonotic disease treatment market share, detailed zoonotic disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the zoonotic disease treatment industry. This zoonotic disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The zoonotic disease treatment market size has grown strongly in recent years. It will grow from $39.71 billion in 2024 to $42.51 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to the emergence of major zoonotic outbreaks, urbanization, and habitat encroachment, one health approach, increased surveillance and reporting, globalization, and increased travel and public awareness and education.

The zoonotic disease treatment market size is expected to see strong growth in the next few years. It will grow to $54.84 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to climate change and environmental factors, government and international funding, advancements in medical technology, regulatory support and streamlined approvals, and collaborative research and development. Major trends in the forecast period include the development of broad-spectrum antivirals, strengthening global health infrastructure, advances in diagnostic technology, growth in vaccine development platforms, and focus on preventive measures.

The forecast of 6.6% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Restrictions on cross-border shipment of therapeutics and diagnostic kits may weaken zoonotic disease control programs and elevate outbreak response costs.

The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing demand for animal proteins is expected to drive the growth of the zoonotic disease treatment market in the coming years. Animal proteins, derived from sources such as meat, dairy, eggs, and fish, provide all essential amino acids required for human health. This rise in demand is attributed to factors like the increasing global population, higher income levels, urbanization, and greater awareness of the nutritional benefits of animal-based foods. Zoonotic disease treatments are crucial for managing diseases associated with animal proteins, helping to understand transmission pathways, develop effective therapies, and implement preventive measures to reduce public health risks. For example, in July 2023, a report from the Organization for Economic Co-operation and Development and the Food and Agriculture Organization highlighted that global meat consumption is projected to grow at an annual rate of 0.1%. This increase is mainly driven by rising demand in middle and lower-income countries, with poultry expected to contribute nearly half of the total growth in meat production by 2032.

Major companies in the zoonotic disease treatment market are increasingly investing in advanced diagnostic technologies and treatment protocols to improve the identification and management of zoonotic diseases. These efforts include developing tools such as PCR kits for faster identification of zoonotic pathogens and implementing targeted therapeutic interventions. For example, in October 2023, BioPerfectus, a China-based biotechnology company specializing in diagnostic solutions, expanded its Zoonotic Infectious Diseases Total PCR Solution by adding thirteen new members. This enhancement aims to strengthen its diagnostic capabilities for zoonotic diseases, which are responsible for more than 60% of known infectious diseases and 75% of emerging infections. The initiative is designed to improve health security and response, especially as climate change facilitates the spread of infectious diseases to new regions. With these new products, BioPerfectus aims to enable quicker diagnoses and better management of zoonotic infections, emphasizing the need for proactive public health measures.

In May 2022, Ceva Sante Animale, a veterinary pharmaceutical company headquartered in France, purchased Artemis Technologies Inc. for an undisclosed sum. This strategic acquisition bolsters Ceva's current rabies portfolio and extensive proficiency in manufacturing oral rabies vaccines and conducting rabies vaccination campaigns throughout Europe and other territories. Artemis Technologies Inc., based in Canada, specializes in supplying vaccines for zoonotic diseases.

Major companies operating in the zoonotic disease treatment market are Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis International AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Zoetis Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, IDEXX Laboretories Inc., Hikma Pharmaceuticals PLC., Ceva Sante Animale, Vir Biotechnology Inc., Virbac, Vetoquinol S.A., BioCryst Pharmaceuticals Inc, Heska Corporation

North America was the largest region in the zoonotic disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zoonotic disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the zoonotic disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The zoonotic disease treatment market consists of revenues earned by entities by providing services such as vaccinations, antimicrobial therapy, supportive care, and vector control. The market value includes the value of related goods sold by the service provider or included within the service offering. The zoonotic disease treatment market also includes sales of diagnostic kits, antimicrobial medications (antiparasitic, immunomodulators), and vector control products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Zoonotic Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on zoonotic disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for zoonotic disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The zoonotic disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease Type: Rabies; Tuberculosis; Malaria; Leishmaniasis; Ebola Virus Disease; Other Disease Types
• 2) By Drug Class: Anti-Fungal; Anti-Bacterial; Antibiotics; Other Drug Classes
• 3) By Causative Agent: Bacteria; Virus; Nematode; Rodents; Ticks; Other Causative Agents
• 4) By Route Of Administration: Oral; Topical; Other Routes Of Administrations
• 5) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
• Subsegments:
• 1) By Rabies: Post Exposure Prophylaxis (PEP); Pre-Exposure Prophylaxis (PrEP)
• 2) By Tuberculosis: Latent Tuberculosis Treatment; Active Tuberculosis Treatment
• 3) By Malaria: Plasmodium falciparum Malaria; Plasmodium Vivax Malaria; Other Malaria Types
• 4) By Leishmaniasis: Visceral Leishmaniasis; Cutaneous Leishmaniasis; Mucocutaneous Leishmaniasis
• 5) By Ebola Virus Disease: Pre-Exposure Vaccination; Post-Exposure Treatment
• 6) By Other Disease Types: Zika Virus; Lassa Fever; Yellow Fever; Chikungunya
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Merck And Co. Inc.; Bayer AG; Sanofi S.A.; AstraZeneca plc; Novartis International AG; F. Hoffmann-La Roche Ltd.; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Teva Pharmaceutical Industries Ltd.; Zoetis Inc.; Boehringer Ingelheim International GmbH; Elanco Animal Health Incorporated; IDEXX Laboretories Inc.; Hikma Pharmaceuticals PLC.; Ceva Sante Animale; Vir Biotechnology Inc.; Virbac; Vetoquinol S.A.; BioCryst Pharmaceuticals Inc; Heska Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Zoonotic Disease Treatment Market Characteristics

3. Zoonotic Disease Treatment Market Trends And Strategies

4. Zoonotic Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Zoonotic Disease Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Zoonotic Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Zoonotic Disease Treatment Market Growth Rate Analysis
• 5.4. Global Zoonotic Disease Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Zoonotic Disease Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Zoonotic Disease Treatment Total Addressable Market (TAM)

6. Zoonotic Disease Treatment Market Segmentation

• 6.1. Global Zoonotic Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rabies
• Tuberculosis
• Malaria
• Leishmaniasis
• Ebola Virus Disease
• Other Disease Types
• 6.2. Global Zoonotic Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anti-Fungal
• Anti-Bacterial
• Antibiotics
• Other Drug Classes
• 6.3. Global Zoonotic Disease Treatment Market, Segmentation By Causative Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bacteria
• Virus
• Nematode
• Rodents
• Ticks
• Other Causative Agents
• 6.4. Global Zoonotic Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Topical
• Other Routes Of Administrations
• 6.5. Global Zoonotic Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Other Distribution Channels
• 6.6. Global Zoonotic Disease Treatment Market, Sub-Segmentation Of Rabies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Post Exposure Prophylaxis (PEP)
• Pre-Exposure Prophylaxis (PrEP)
• 6.7. Global Zoonotic Disease Treatment Market, Sub-Segmentation Of Tuberculosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Latent Tuberculosis Treatment
• Active Tuberculosis Treatment
• 6.8. Global Zoonotic Disease Treatment Market, Sub-Segmentation Of Malaria, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Plasmodium falciparum Malaria
• Plasmodium Vivax Malaria
• Other Malaria Types
• 6.9. Global Zoonotic Disease Treatment Market, Sub-Segmentation Of Leishmaniasis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Visceral Leishmaniasis
• Cutaneous Leishmaniasis
• Mucocutaneous Leishmaniasis
• 6.10. Global Zoonotic Disease Treatment Market, Sub-Segmentation Of Ebola Virus Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pre-Exposure Vaccination
• Post-Exposure Treatment
• 6.11. Global Zoonotic Disease Treatment Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Zika Virus
• Lassa Fever
• Yellow Fever
• Chikungunya

7. Zoonotic Disease Treatment Market Regional And Country Analysis

• 7.1. Global Zoonotic Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Zoonotic Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Zoonotic Disease Treatment Market

• 8.1. Asia-Pacific Zoonotic Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Zoonotic Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Zoonotic Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Zoonotic Disease Treatment Market, Segmentation By Causative Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Zoonotic Disease Treatment Market

• 9.1. China Zoonotic Disease Treatment Market Overview
• 9.2. China Zoonotic Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Zoonotic Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Zoonotic Disease Treatment Market, Segmentation By Causative Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Zoonotic Disease Treatment Market

• 10.1. India Zoonotic Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Zoonotic Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Zoonotic Disease Treatment Market, Segmentation By Causative Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Zoonotic Disease Treatment Market

• 11.1. Japan Zoonotic Disease Treatment Market Overview
• 11.2. Japan Zoonotic Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Zoonotic Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Zoonotic Disease Treatment Market, Segmentation By Causative Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Zoonotic Disease Treatment Market

• 12.1. Australia Zoonotic Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Zoonotic Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Zoonotic Disease Treatment Market, Segmentation By Causative Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Zoonotic Disease Treatment Market

• 13.1. Indonesia Zoonotic Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Zoonotic Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Zoonotic Disease Treatment Market, Segmentation By Causative Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Zoonotic Disease Treatment Market

• 14.1. South Korea Zoonotic Disease Treatment Market Overview
• 14.2. South Korea Zoonotic Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Zoonotic Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Zoonotic Disease Treatment Market, Segmentation By Causative Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Zoonotic Disease Treatment Market

• 15.1. Western Europe Zoonotic Disease Treatment Market Overview
• 15.2. Western Europe Zoonotic Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Zoonotic Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Zoonotic Disease Treatment Market, Segmentation By Causative Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Zoonotic Disease Treatment Market

• 16.1. UK Zoonotic Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Zoonotic Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Zoonotic Disease Treatment Market, Segmentation By Causative Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Zoonotic Disease Treatment Market

• 17.1. Germany Zoonotic Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Zoonotic Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Zoonotic Disease Treatment Market, Segmentation By Causative Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Zoonotic Disease Treatment Market

• 18.1. France Zoonotic Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Zoonotic Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Zoonotic Disease Treatment Market, Segmentation By Causative Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Zoonotic Disease Treatment Market

• 19.1. Italy Zoonotic Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Zoonotic Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Zoonotic Disease Treatment Market, Segmentation By Causative Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Zoonotic Disease Treatment Market

• 20.1. Spain Zoonotic Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Zoonotic Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Zoonotic Disease Treatment Market, Segmentation By Causative Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Zoonotic Disease Treatment Market

• 21.1. Eastern Europe Zoonotic Disease Treatment Market Overview
• 21.2. Eastern Europe Zoonotic Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Zoonotic Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Zoonotic Disease Treatment Market, Segmentation By Causative Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Zoonotic Disease Treatment Market

• 22.1. Russia Zoonotic Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Zoonotic Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Zoonotic Disease Treatment Market, Segmentation By Causative Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Zoonotic Disease Treatment Market

• 23.1. North America Zoonotic Disease Treatment Market Overview
• 23.2. North America Zoonotic Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Zoonotic Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Zoonotic Disease Treatment Market, Segmentation By Causative Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Zoonotic Disease Treatment Market

• 24.1. USA Zoonotic Disease Treatment Market Overview
• 24.2. USA Zoonotic Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Zoonotic Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Zoonotic Disease Treatment Market, Segmentation By Causative Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Zoonotic Disease Treatment Market

• 25.1. Canada Zoonotic Disease Treatment Market Overview
• 25.2. Canada Zoonotic Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Zoonotic Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Zoonotic Disease Treatment Market, Segmentation By Causative Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Zoonotic Disease Treatment Market

• 26.1. South America Zoonotic Disease Treatment Market Overview
• 26.2. South America Zoonotic Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Zoonotic Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Zoonotic Disease Treatment Market, Segmentation By Causative Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Zoonotic Disease Treatment Market

• 27.1. Brazil Zoonotic Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Zoonotic Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Zoonotic Disease Treatment Market, Segmentation By Causative Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Zoonotic Disease Treatment Market

• 28.1. Middle East Zoonotic Disease Treatment Market Overview
• 28.2. Middle East Zoonotic Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Zoonotic Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Zoonotic Disease Treatment Market, Segmentation By Causative Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Zoonotic Disease Treatment Market

• 29.1. Africa Zoonotic Disease Treatment Market Overview
• 29.2. Africa Zoonotic Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Zoonotic Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Zoonotic Disease Treatment Market, Segmentation By Causative Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Zoonotic Disease Treatment Market Competitive Landscape And Company Profiles

• 30.1. Zoonotic Disease Treatment Market Competitive Landscape
• 30.2. Zoonotic Disease Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Zoonotic Disease Treatment Market Other Major And Innovative Companies

• 31.1. AstraZeneca plc
• 31.2. Novartis International AG
• 31.3. F. Hoffmann-La Roche Ltd.
• 31.4. GlaxoSmithKline plc
• 31.5. Takeda Pharmaceutical Company Limited
• 31.6. Eli Lilly and Company
• 31.7. Teva Pharmaceutical Industries Ltd.
• 31.8. Zoetis Inc.
• 31.9. Boehringer Ingelheim International GmbH
• 31.10. Elanco Animal Health Incorporated
• 31.11. IDEXX Laboretories Inc.
• 31.12. Hikma Pharmaceuticals PLC.
• 31.13. Ceva Sante Animale
• 31.14. Vir Biotechnology Inc.
• 31.15. Virbac

32. Global Zoonotic Disease Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Zoonotic Disease Treatment Market

34. Recent Developments In The Zoonotic Disease Treatment Market

35. Zoonotic Disease Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Zoonotic Disease Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Zoonotic Disease Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Zoonotic Disease Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer